Product Pathways - NF-kB Signaling
ABIN-1 Antibody #4664
|4664S||100 µl (10 western blots)||---||In Stock||---|
|4664||carrier free and custom formulation / quantity||email request|
|W||1:1000||Human, Mouse, Rat||Endogenous||80-85||Rabbit|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting, IP=Immunoprecipitation
Species predicted to react based on 100% sequence homology: Monkey.
Specificity / Sensitivity
ABIN-1 Antibody detects endogenous levels of total ABIN-1 protein.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human ABIN-1 protein. Antibodies are purified by protein A and peptide affinity chromatography.
Western blot analysis of extracts from Raji, HEL and Daudi cells using ABIN-1 Antibody.
The ABIN family (ABIN-1, -2, and -3) is a group of adaptor proteins that associate and cooperate with A20/TNFAIP3 (1), a ubiquitin editing protein that inhibits the key inflammatory transcription factor NF-κB (2-4). Mechanistically, A20 acts by regulating the ubiquitination of the kinase RIP, which leads to inhibition of the IKK complex (5).
ABIN-1 (Naf1/TNIP1) was identified based on its binding to A20 (6), as well as the HIV protein Nef-1 (7). Overexpression of ABIN-1 inhibits NF-κB activation by a number of stimuli including TNF, IL-1, and LPS. It is widely expressed and can be induced by NF-κB, providing a negative feedback loop of NF-κB signaling. In addition to binding to A20, ABIN-1 can function on other key components of NF-κB signaling including IKKγ/NEMO (8) and NF-κB family members p100 and p105 (9), and can also inhibit ERK signaling (10). Knockout mice of ABIN-1 are embryonic lethal, with fetal liver apoptosis, anemia and hypoplasia (11). ABIN-1 deficient cells are hypersensitive to TNF-mediated apoptosis.
- Verstrepen, L. et al. (2009) Biochem Pharmacol 78, 105-14.
- Beyaert, R. et al. (2000) Biochem Pharmacol 60, 1143-51.
- Lee, E.G. et al. (2000) Science 289, 2350-4.
- Dixit, V.M. et al. (1990) J Biol Chem 265, 2973-8.
- Wertz, I.E. et al. (2004) Nature 430, 694-9.
- Heyninck, K. et al. (1999) J Cell Biol 145, 1471-82.
- Fukushi, M. et al. (1999) FEBS Lett 442, 83-8.
- Mauro, C. et al. (2006) J Biol Chem 281, 18482-8.
- Cohen, S. et al. (2009) Biochem Biophys Res Commun 389, 205-10.
- Zhang, S. et al. (2002) Biochem Biophys Res Commun 297, 17-23.
- Oshima, S. et al. (2009) Nature 457, 906-9.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.